THC - Tenet Healthcare Non-GAAP EPS of $1.44 beats by $0.22 revenue of $4.8B in-line
- Tenet Healthcare press release ( NYSE: THC ): Q3 Non-GAAP EPS of $1.44 beats by $0.22 .
- Revenue of $4.8B (-1.8% Y/Y) in-line.
- Third Quarter 2022 USPI Adjusted EBITDA grew 16.4% over third quarter 2021
- Same-facility system-wide ambulatory surgical cases were flat compared to third quarter 2021; Same-hospital adjusted admissions decreased 0.7% versus third quarter 2021
- Board of Directors has authorized a $1 billion share repurchase program
- FY 2022 Adjusted EBITDA Outlook range revised to $3.375 billion to $3.475 billion, a ~1% change to the mid-point of the previous Outlook range.
- Shares -6.11% .
For further details see:
Tenet Healthcare Non-GAAP EPS of $1.44 beats by $0.22, revenue of $4.8B in-line